Gene therapy pioneer Voyager Therapeutics Inc (stock code: VYGR) announced that by the end of fiscal year 2025, the company held strong cash and cash equivalents totaling $202 million.

Procore: Director Kevin J. O’Connor reported selling 15,384 common shares on Oct. 5-6. Sales prices ranged from $52.83 to $55.08 per share. Indirect holding fell to 908,286 shares, held via the Kevin J. O’Connor Revocable Trust. O’Connor also reported 21,344 shares held directly. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Procore Technologies Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001628280-26-065378), on October 07, 2026, and is solely responsible for the information contained therein.

Microsoft held a Surface product launch event on Wednesday, announcing the price and release schedule for the new flagship Surface Laptop Ultra equipped with Nvidia chips. Microsoft also stated that the device outperforms competing Apple products in certain artificial intelligence (AI) tasks.

Former Wedbush tech analyst Dan Ives released his top picks for the technology sector in 2027 on Wednesday, listing Nvidia, Microsoft, Palantir, Apple, and CrowdStrike as his five top technology choices.